Aptinyx Recommences Patient Recruitment in Phase 2 Study of NYX-2925 in Patients with Fibromyalgia by Seini Moimoi | Sep 28, 2020 | Portfolio News
Longitude Capital Raises $585 Million Fund to Invest in Transformative Healthcare Companies by Seini Moimoi | Sep 23, 2020 | Longitude Capital News
Axonics® Receives Health Canada Approval of Next Generation Implantable Neurostimulator by Seini Moimoi | Sep 21, 2020 | Portfolio News
Checkmate Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides an Update on Recent Progress by Seini Moimoi | Sep 18, 2020 | Portfolio News
